✅ Benefits

• Dual-acting antidiabetic therapy: Sitagliptin enhances post-meal insulin secretion by inhibiting DPP‑4; Metformin decreases hepatic glucose production and improves insulin sensitivity ([turn0search0], [turn0search1]).

• Effective glycemic control when monotherapy is insufficient—helps reduce fasting and postprandial blood glucose levels ([turn0search1]).

• Flexible dosing regimen: One tablet twice daily with meals. Dose can be increased gradually—max daily limit is Sitagliptin 100 mg and Metformin 2000 mg ([turn0search1]).

• Generally well tolerated, common side effects include diarrhea, nausea, headache, gastric upset, upper respiratory infection, and fatigue. Risk of hypoglycemia increases if used with insulin or sulfonylureas ([turn0search1]).

• Convenient and accessible: daily dosing twice with meals; tablets should be swallowed whole—not crushed or chewed. Use caution in renal and hepatic impairment ([turn0search1]).

• Affordable pricing in Bangladesh: Approx. ৳18 per tablet (strip of 10 costs around ৳180) ([turn0search1], [turn0search5]).

• Backed by local regulator approval: Listed under DGDA registration; manufactured by trusted local company ACME Laboratories Ltd. ([turn0search6]).